questionsmedicales.fr
Technologie, industrie et agriculture
Produits manufacturés
Matériaux biomédicaux et dentaires
Adhésifs tissulaires
Cyanoacrylates
Enbucrilate
2-Cyano-acrylate d'isobutyle
2-Cyano-acrylate d'isobutyle : Questions médicales fréquentes
Termes MeSH sélectionnés :
Angiotensin-Converting Enzyme 2
Diagnostic
2
Adhésifs
Chirurgie
Plaies
Allergies
Antécédents médicaux
Chirurgie
Symptômes
2
Réaction cutanée
Symptômes
Dermatologie
Douleur
Chirurgie
Effets indésirables
Prévention
2
Allergies
Prévention
Chirurgie
Précautions
Chirurgie
Stérilité
Traitements
2
Infections
Chirurgie
Plaies
Cicatrisation
Adhésifs
Chirurgie
Complications
2
Complications
Infections
Cicatrices
Réactions systémiques
Allergies
Chirurgie
Facteurs de risque
2
Facteurs de risque
Allergies
Chirurgie
Enfants
Chirurgie
Adhésifs
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "2-Cyano-acrylate d'isobutyle : Questions médicales les plus fréquentes",
"headline": "2-Cyano-acrylate d'isobutyle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les 2-Cyano-acrylate d'isobutyle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-15",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "2-Cyano-acrylate d'isobutyle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Enbucrilate",
"url": "https://questionsmedicales.fr/mesh/D004659",
"about": {
"@type": "MedicalCondition",
"name": "Enbucrilate",
"code": {
"@type": "MedicalCode",
"code": "D004659",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.051.919.367.341"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "2-Cyano-acrylate d'isobutyle",
"alternateName": "Bucrylate",
"code": {
"@type": "MedicalCode",
"code": "D002015",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Michael Schultheiß",
"url": "https://questionsmedicales.fr/author/Michael%20Schulthei%C3%9F",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Max Giesler",
"url": "https://questionsmedicales.fr/author/Max%20Giesler",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Lars Maruschke",
"url": "https://questionsmedicales.fr/author/Lars%20Maruschke",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Arthur Schmidt",
"url": "https://questionsmedicales.fr/author/Arthur%20Schmidt",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Lukas Sturm",
"url": "https://questionsmedicales.fr/author/Lukas%20Sturm",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36787743",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cell.2023.01.039"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of spike proteins on angiotensin converting enzyme 2 (ACE2).",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37769892",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.abb.2023.109769"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients.",
"datePublished": "2023-04-14",
"url": "https://questionsmedicales.fr/article/37060024",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40360-023-00667-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum levels of angiotensin-converting enzyme 2 in children with Kawasaki disease.",
"datePublished": "2022-11-07",
"url": "https://questionsmedicales.fr/article/36344782",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10238-022-00933-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Angiotensin-Converting Enzyme 2 (ACE2) Gene Polymorphism in Patients with Type 2 Diabetes (",
"datePublished": "2022-12-31",
"url": "https://questionsmedicales.fr/article/37274884",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.22092/ARI.2022.358736.2294"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Technologie, industrie et agriculture",
"item": "https://questionsmedicales.fr/mesh/D013676"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits manufacturés",
"item": "https://questionsmedicales.fr/mesh/D008420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Matériaux biomédicaux et dentaires",
"item": "https://questionsmedicales.fr/mesh/D001697"
},
{
"@type": "ListItem",
"position": 5,
"name": "Adhésifs tissulaires",
"item": "https://questionsmedicales.fr/mesh/D014014"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cyanoacrylates",
"item": "https://questionsmedicales.fr/mesh/D003487"
},
{
"@type": "ListItem",
"position": 7,
"name": "Enbucrilate",
"item": "https://questionsmedicales.fr/mesh/D004659"
},
{
"@type": "ListItem",
"position": 8,
"name": "2-Cyano-acrylate d'isobutyle",
"item": "https://questionsmedicales.fr/mesh/D002015"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : 2-Cyano-acrylate d'isobutyle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur 2-Cyano-acrylate d'isobutyle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur 2-Cyano-acrylate d'isobutyle",
"description": "Comment le Bucrylate est-il utilisé en diagnostic ?\nQuels tests sont nécessaires avant d'utiliser le Bucrylate ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Angiotensin-Converting+Enzyme+2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur 2-Cyano-acrylate d'isobutyle",
"description": "Quels symptômes peuvent survenir après l'application de Bucrylate ?\nLe Bucrylate peut-il provoquer des douleurs ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Angiotensin-Converting+Enzyme+2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur 2-Cyano-acrylate d'isobutyle",
"description": "Comment prévenir les réactions allergiques au Bucrylate ?\nQuelles précautions doivent être prises lors de l'utilisation du Bucrylate ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Angiotensin-Converting+Enzyme+2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur 2-Cyano-acrylate d'isobutyle",
"description": "Le Bucrylate est-il utilisé pour traiter des infections ?\nComment le Bucrylate favorise-t-il la cicatrisation ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Angiotensin-Converting+Enzyme+2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur 2-Cyano-acrylate d'isobutyle",
"description": "Quelles complications peuvent survenir avec le Bucrylate ?\nLe Bucrylate peut-il causer des réactions systémiques ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Angiotensin-Converting+Enzyme+2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur 2-Cyano-acrylate d'isobutyle",
"description": "Qui est à risque d'allergie au Bucrylate ?\nLes enfants peuvent-ils utiliser le Bucrylate ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Angiotensin-Converting+Enzyme+2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le Bucrylate est-il utilisé en diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'est pas utilisé pour le diagnostic, mais pour la fermeture des plaies."
}
},
{
"@type": "Question",
"name": "Quels tests sont nécessaires avant d'utiliser le Bucrylate ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun test spécifique n'est requis, mais l'historique allergique doit être vérifié."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent survenir après l'application de Bucrylate ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rougeurs, démangeaisons ou gonflements peuvent apparaître au site d'application."
}
},
{
"@type": "Question",
"name": "Le Bucrylate peut-il provoquer des douleurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs légères peuvent survenir, mais elles sont généralement temporaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les réactions allergiques au Bucrylate ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer l'historique allergique et effectuer un test cutané si nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles précautions doivent être prises lors de l'utilisation du Bucrylate ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec les yeux et les muqueuses, et utiliser dans un environnement stérile."
}
},
{
"@type": "Question",
"name": "Le Bucrylate est-il utilisé pour traiter des infections ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il est utilisé pour la fermeture des plaies, pas pour traiter les infections."
}
},
{
"@type": "Question",
"name": "Comment le Bucrylate favorise-t-il la cicatrisation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il forme une barrière protectrice qui aide à maintenir l'humidité et à réduire l'infection."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le Bucrylate ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections, des réactions allergiques ou des cicatrices anormales peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le Bucrylate peut-il causer des réactions systémiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions systémiques sont rares, mais possibles en cas d'allergie sévère."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'allergie au Bucrylate ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents d'allergies aux adhésifs ou aux cyanoacrylates."
}
},
{
"@type": "Question",
"name": "Les enfants peuvent-ils utiliser le Bucrylate ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais avec prudence et sous supervision médicale en raison de leur peau sensible."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/04/2025
Contenu vérifié selon les dernières recommandations médicales
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. Martin-Roessle@t-online.de.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
ACE2 is the indispensable entry receptor for SARS-CoV and SARS-CoV-2. Because of the COVID-19 pandemic, it has become one of the most therapeutically targeted human molecules in biomedicine. ACE2 serv...
The Coronavirus Disease 2019 (COVID-19) pandemic was caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which enters host cells through interactions of its spike protein to Angiot...
Renin-angiotensin-aldosterone system (RAAS) is hypothesized to be in the center of COVID pathophysiology as the angiotensin converting enzyme 2 (ACE2) represents the main entrance of the virus, thus t...
A total of 40 healthy controls and 60 Egyptian patients suffering from chronic cardiovascular diseases were enrolled in this study. Patients were divided into 40 patients treated with ACEIs and 20 pat...
Assessment of serum ACE2 level in different groups showed a significant difference between ACEIs and healthy groups and ACEIs and ARBs group, while there was no difference between ARBs and healthy. Mu...
ACE2 levels varied between ACEIs and ARBs. It tends to be lower in ACEIs group and there is a strong positive association between ACE2 level and the female sex. This needs to be considered in Future s...
Retrospectively registered ClinicalTrials.gov ID: NCT05418361 (June 2022)....
Kawasaki disease (KD) has replaced rheumatic fever as the main cause of acquired heart disease in Japanese, American, and Chinese children. Polymorphisms in angiotensin-converting enzyme may be associ...
The increased levels of blood glucose associated with genetic and/or environmental risk factors have been known as Type 2 diabetes mellitus (T2D). T2D is categorized as a dangerous clinical syndrome f...
Rapid and cost-effective diagnostic tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are a critical and valuable weapon for the coronavirus disease 2019 (COVID-19) pandemic respo...
In order to prevent COVID-19 from progressing, angiotensin-converting enzyme 2 (ACE2) binds to SARS-CoV-2 and prevents the virus from entering target cells. Several studies have found a correlation be...
We conducted a systematic review using PubMed, Embase, Cochrane Library, Scopus, Science Direct and Web of Science databases. The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. ...
It was concluded that the ACE2 G8790A polymorphism was not associated with COVID-19 based on the data collected. Moreover, subgroup analyses stratified based on race proved that the ACE2 G allele show...
The findings indicated that the G allele of ACE2 G8790A was related to an enhanced risk of COVID-19 severity in Asians. One possible reason is that ACE2 G allele was associated with a COVID-19 cytokin...
Systemic sclerosis (SSc) is a disease with cardiovascular impairment and polymorphisms of the gene coding of angiotensin-converting-enzyme 2 (ACE2) may account for its development. Three single nucleo...
Genomic DNA was isolated from whole blood. Restriction-fragment-length polymorphism was used for genotyping of rs1978124, while detection of rs879922 and rs2285666 was based on TaqMan SNP Genotyping A...
81 SSc patients (60 women, 21 men) were enrolled. Allele C of rs879922 polymorphism was associated with significantly greater risk for development of AH (OR=2.5, p=0.018), but less frequent joint invo...
Polymorphisms of ACE2 may account for the development of AH and CVS disorders in SSc patients. Strong tendencies to more frequent occurrence of disease specific characteristics distinct to macrovascul...
The quick and advancing prevalence of the new coronavirus SARS-CoV-2 produced a global crisis surge with a profound impact on human health and worldwide economic constancy. The virus is known as one s...
The Angiotensin-Converting Enzyme 2 (ACE2) is the main receptor of the SARS-CoV-2. There is contradictory evidence on how the exposure to nicotine may module the concentration of soluble ACE2 (sACE2)....
Pooled analysis performed with data retrieved from two studies (n = 634 and n = 302). Geometric mean (GM) concentrations of sACE2, both total and relative to the total amount of protein in the sample,...
We observed a significant increase of 0.108‰ and 0.087 ng/μl in the relative and absolute salivary sACE2 GM concentrations, respectively, between the lowest and highest nicotine levels. Similar result...
Salivary nicotine concentration seems to be limitedly associated with the concentration of sACE2....